Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
2 hedge funds and large institutions have $6.63M invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
71% less funds holding
Funds holding: 7 → 2 (-5)
90% less capital invested
Capital invested by funds: $69.6M → $6.63M (-$63M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rational Advisors
Huntington,
New York
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$53M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$6.1M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$3.29M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.16M |
| 5 |
CWM
Calamos Wealth Management
Naperville,
Illinois
|
-$854K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
1
Rational Advisors
Huntington,
New York
| $3.8M | +$1.61M | +14,570 | +71% |
|
|
LTI
2
Laffer Tengler Investments
Nashville,
Tennessee
| $2.82M | -$105K | -948 | -4% |
|
|
3
Calamos Advisors
Naperville,
Illinois
| – | -$53M | -484,157 | Closed |
|
|
PI
4
Putnam Investments
Boston,
Massachusetts
| – | -$6.1M | -55,818 | Closed |
|
|
PCM
5
Pentwater Capital Management
Naples,
Florida
| – | -$3.29M | -30,000 | Closed |
|
|
6
Russell Investments Group
London,
United Kingdom
| – | -$1.16M | -10,636 | Closed |
|
|
CWM
7
Calamos Wealth Management
Naperville,
Illinois
| – | -$854K | -7,797 | Closed |
|
BSX.PRA Hedge Fund Activity: Q1 2021 in Review
2 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q1 2021, worth a combined $6.63M — down 90% from $69.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BSX.PRA and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Rational Advisors, adding an estimated $1.61M. The largest seller was Calamos Advisors, exiting entirely with an estimated $53M sold.
- 2 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q1 2021, down from 7 in Q4 2020.
- Funds reported $6.63M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q1 2021, down 90% quarter-over-quarter.
- 0 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q1 2021 and 5 closed out, a net change of -5 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q1 2021 was Rational Advisors, an estimated $1.61M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q1 2021 was Calamos Advisors, an estimated $53M sold.
Based on aggregated 13F filings for Q1 2021.